DE69834024D1 - Tetracycline verbindungen zur behandlung von spezifischen krebsarten - Google Patents

Tetracycline verbindungen zur behandlung von spezifischen krebsarten

Info

Publication number
DE69834024D1
DE69834024D1 DE69834024T DE69834024T DE69834024D1 DE 69834024 D1 DE69834024 D1 DE 69834024D1 DE 69834024 T DE69834024 T DE 69834024T DE 69834024 T DE69834024 T DE 69834024T DE 69834024 D1 DE69834024 D1 DE 69834024D1
Authority
DE
Germany
Prior art keywords
cells
cancer
growth
tetracycline compounds
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69834024T
Other languages
English (en)
Other versions
DE69834024T2 (de
Inventor
M Golub
F Mcnamara
S Ramamurthy
Hsi-Ming Lee
Sanford Simon
L Lokeshwar
G Selzer
L Block
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of State University of New York
University of Miami
Original Assignee
Research Foundation of State University of New York
University of Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation of State University of New York, University of Miami filed Critical Research Foundation of State University of New York
Publication of DE69834024D1 publication Critical patent/DE69834024D1/de
Application granted granted Critical
Publication of DE69834024T2 publication Critical patent/DE69834024T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69834024T 1997-01-15 1998-01-15 Tetracycline verbindungen zur behandlung von spezifischen krebsarten Expired - Lifetime DE69834024T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US783655 1997-01-15
US08/783,655 US5837696A (en) 1997-01-15 1997-01-15 Method of inhibiting cancer growth
PCT/US1998/000332 WO1998031224A1 (en) 1997-01-15 1998-01-15 Method of inhibiting cancer growth

Publications (2)

Publication Number Publication Date
DE69834024D1 true DE69834024D1 (de) 2006-05-18
DE69834024T2 DE69834024T2 (de) 2006-12-07

Family

ID=25130005

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69834024T Expired - Lifetime DE69834024T2 (de) 1997-01-15 1998-01-15 Tetracycline verbindungen zur behandlung von spezifischen krebsarten

Country Status (11)

Country Link
US (2) US5837696A (de)
EP (1) EP0971585B1 (de)
JP (1) JP4428727B2 (de)
KR (1) KR20000070212A (de)
AT (1) ATE321452T1 (de)
AU (1) AU729886B2 (de)
CA (1) CA2277865C (de)
DE (1) DE69834024T2 (de)
ES (1) ES2262221T3 (de)
PT (1) PT971585E (de)
WO (1) WO1998031224A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837696A (en) * 1997-01-15 1998-11-17 The Research Foundation Of State University Of New York Method of inhibiting cancer growth
US6429204B1 (en) 1997-01-15 2002-08-06 University Of Miami Method of inhibiting cancer growth
AU2001599A (en) * 1997-12-19 1999-07-05 New York University Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
US6277061B1 (en) 1998-03-31 2001-08-21 The Research Foundation Of State University Of New York Method of inhibiting membrane-type matrix metalloproteinase
US6015804A (en) * 1998-09-11 2000-01-18 The Research Foundation Of State University Of New York Method of using tetracycline compounds to enhance interleukin-10 production
US5977091A (en) * 1998-09-21 1999-11-02 The Research Foundation Of State University Of New York Method of preventing acute lung injury
JP2002533387A (ja) * 1998-12-23 2002-10-08 ジー．ディー．サール ＆ カンパニー 腫瘍治療の複合療法としてインテグリン拮抗物質と一つ以上の抗腫瘍剤を使用する方法
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6984619B1 (en) * 1999-03-19 2006-01-10 Arch Development Corporation Method for protection against tumor metastasis formation
DE10032256C2 (de) * 2000-07-03 2003-06-05 Infineon Technologies Ag Chip-ID-Register-Anordnung
EP1383483A4 (de) * 2001-04-05 2006-08-09 Collagenex Pharm Inc Kontrollierte freisetzung von tetracyclin-verbindungen und tetracyclin-derivativen
EP2332548A1 (de) 2001-07-13 2011-06-15 Paratek Pharmaceuticals, Inc. Tetracyclinverbindungen zur Behandlung von Schlaganfall
US20060194773A1 (en) * 2001-07-13 2006-08-31 Paratek Pharmaceuticals, Inc. Tetracyline compounds having target therapeutic activities
RU2300380C2 (ru) * 2001-10-05 2007-06-10 Тетрадженекс Фармасьютикалс, Инк. Производные тетрациклина и способы их применения
PE20030701A1 (es) * 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
AU2003235759A1 (en) 2002-01-08 2003-07-24 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
EP1482926A4 (de) 2002-03-08 2006-04-12 Paratek Pharm Innc Amino-methyl-substituierte tetracyclin-verbindungen
KR101025400B1 (ko) 2002-03-21 2011-03-28 파라테크 파마슈티컬스, 인크. 치환된 테트라시클린 화합물
US20050153943A1 (en) * 2002-05-06 2005-07-14 Ashley Robert A. Methods of simultaneously treating mucositis and fungal infection
EP1505961A4 (de) * 2002-05-20 2009-09-02 Collagenex Pharm Inc Verfahren zur behandlung allergischer reaktionen
AU2003261161B2 (en) 2002-07-12 2009-09-10 Paratek Pharmaceuticals, Inc 3, 10, and 12a substituted tetracycline compounds
WO2004038000A2 (en) * 2002-10-24 2004-05-06 Paratek Pharmaceuticals, Inc. Methods of using substituted tetracycline compounds to modulate rna
CA2803922C (en) 2003-04-07 2015-09-15 Supernus Pharmaceuticals, Inc. Once daily formulations of tetracyclines
US20050137174A1 (en) 2003-07-09 2005-06-23 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
EP2319829A1 (de) 2003-07-09 2011-05-11 Paratek Pharmaceuticals, Inc. 9-subsituierte Tetracycline-Verbindungen
CA2553510C (en) 2004-01-15 2012-09-25 Paratek Pharmaceuticals, Inc. Aromatic a-ring derivatives of tetracycline compounds
EP2284151A3 (de) 2004-10-25 2011-09-21 Paratek Pharmaceuticals, Inc. Substituierte Tetracyclin-Verbindungen
CA2585418A1 (en) 2004-10-25 2006-05-04 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
AU2006272698B2 (en) * 2005-07-21 2012-11-01 Paratek Pharmaceuticals, Inc. 10-substituted tetracyclines and methods of use thereof
US8513223B2 (en) * 2006-12-21 2013-08-20 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of inflammatory skin disorders
BRPI0720569B8 (pt) 2006-12-21 2021-05-25 Paratek Pharm Innc compostos de tetraciclina substituída e uso dos ditos compostos para o tratamento de uma infecção bacteriana, viral ou parasitária
JP2010525069A (ja) 2007-04-27 2010-07-22 パラテック ファーマシューティカルズ インコーポレイテッド アミノアルキルテトラサイクリン化合物の合成方法および精製方法
ES2386926T3 (es) * 2007-07-06 2012-09-06 Paratek Pharmaceuticals, Inc. Métodos para sintetizar minociclina9-sustituida
TW202216656A (zh) * 2008-05-23 2022-05-01 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
SG10201806714PA (en) 2008-08-08 2018-09-27 Tetraphase Pharmaceuticals Inc C7-fluoro substituted tetracycline compounds
CA2761241C (en) 2009-05-08 2018-02-27 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
CA2772386C (en) 2009-08-28 2017-09-19 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
CN102821769A (zh) * 2010-03-10 2012-12-12 大学健康网络 替加环素用于治疗癌症的用途
TWI592390B (zh) 2010-03-31 2017-07-21 四相製藥公司 聚環狀四環素化合物
BR112015004523B1 (pt) 2012-08-31 2020-08-04 Tetraphase Pharmaceuticals, Inc Compostos de tetraciclina, composições farmacêuticas e seus usos
CN105142631A (zh) 2013-01-14 2015-12-09 健康诊所有限公司 抗癌药物和用途
SG11201903327PA (en) 2016-10-19 2019-05-30 Tetraphase Pharmaceuticals Inc Crystalline forms of eravacycline
US11197872B2 (en) 2017-04-21 2021-12-14 Lunella Biotech, Inc. Vitamin C and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (CSCs)
CA3060509A1 (en) 2017-04-21 2018-10-25 Federica Sotgia Targeting hypoxic cancer stem cells (cscs) with doxycycline: implications for improving anti-angiogenic therapy
CA3063450A1 (en) 2017-05-19 2018-11-22 Lunella Biotech, Inc. Companion diagnostics for mitochondrial inhibitors
MX2019013735A (es) 2017-05-19 2020-01-15 Lunella Biotech Inc Antimitoscinas: inhibidores especificos de la biogenesis mitocondrial para erradicar celulas madre cancerosas.
US20210395198A1 (en) 2018-11-09 2021-12-23 Tetraphase Pharmaceuticals, Inc. Polymorphic forms of a compound and uses thereof
CN115006411A (zh) * 2022-07-26 2022-09-06 中南大学湘雅医院 依拉环素类化合物的应用、药物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3016587B2 (ja) * 1989-12-04 2000-03-06 ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク 非ステロイド抗炎症剤及びテトラサイクリンの配合
US5308839A (en) * 1989-12-04 1994-05-03 The Research Foundation Of State University Of New York Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline
US5668122A (en) * 1993-07-28 1997-09-16 Fife; Rose S. Method to treat cancer with tetracyclines
US5563130A (en) * 1994-12-13 1996-10-08 American Cyanamid Company Methods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth
US5574026A (en) * 1994-12-13 1996-11-12 American Cyanamid Company Methods for inhibiting angiogenesis proliferation of endothelial or tumor cells and tumor growth
US5567693A (en) * 1994-12-13 1996-10-22 American Cyanamid Company Method for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth
US5837696A (en) * 1997-01-15 1998-11-17 The Research Foundation Of State University Of New York Method of inhibiting cancer growth

Also Published As

Publication number Publication date
EP0971585A4 (de) 2001-01-24
ATE321452T1 (de) 2006-04-15
DE69834024T2 (de) 2006-12-07
AU5910498A (en) 1998-08-07
EP0971585A1 (de) 2000-01-19
CA2277865C (en) 2009-06-02
PT971585E (pt) 2006-08-31
US6100248A (en) 2000-08-08
WO1998031224A1 (en) 1998-07-23
EP0971585B1 (de) 2006-03-29
CA2277865A1 (en) 1998-07-23
KR20000070212A (ko) 2000-11-25
AU729886B2 (en) 2001-02-15
JP4428727B2 (ja) 2010-03-10
US5837696A (en) 1998-11-17
ES2262221T3 (es) 2006-11-16
JP2001508794A (ja) 2001-07-03

Similar Documents

Publication Publication Date Title
DE69834024D1 (de) Tetracycline verbindungen zur behandlung von spezifischen krebsarten
DE69830072D1 (de) Radioaktive zusammensetzungen zur behandlung von prostatatumoren
EP1019060A4 (de) Androgensyntheseinhibitoren
MX9804009A (es) Inhibicion de crecimiento tumoral por oligonucleotidos de antisentido para il-8 y receptor de il-8.
YU596A (sh) Estrogen agonisti/antagonisti
DE60035204D1 (de) Tyrosinderivate
DE60040981D1 (de) BEHANDLUNG MIT ANTI-ErbB2 ANTIKÖRPERN
ATE295519T1 (de) Behandlung von kohlenwasserstoffgas
DE60015070D1 (de) Verwendung von antikonvulsiven derivaten zur behandlung der cluster headache
ZA988826B (en) Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation
ATE208210T1 (de) Kombination von proteintyrosin-kinaseinhibitoren und chemischer kastration zur behandlung von prostatakrebs
AP9901478A0 (en) Compounds for the treatment of ischemia.
DE602004015811D1 (de) Verfahren zur inhibierung der proliferation von tumorzellen, bei dem platinkomplexe eingesetzt werden
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
HUP0104688A2 (hu) Összetételek és eljárások a rákbetegség és a rákbetegséggel kapcsolódó csontveszteség megelőzéséhez és kezeléséhez
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
DE69825286D1 (de) Verwendung von cholinesterasehemmern zur behandlung von aufmerksamkeitsmangel-störungen
DE69328025D1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
DE69902523D1 (de) Verwendung von erythropoietin zur behandlung von multiple myelom
DE69921130D1 (de) Verfahren und stoffe zur behandlung des prostatakarzinomes
ATE196083T1 (de) Verwendung von ferrioxamin-b zur behandlung septischen schocks
DE60229414D1 (de) Verwendung von aplidine in der behandlung von pankreaskrebs
DE60137721D1 (de) Inhibitoren von lyn-verbundener signaltransduktion (last) und deren verwendung zur behandlung von prostatakrebs
IL189502A0 (en) Methods and compositions for inhibiting neoplastic cell growth
MX9700624A (es) Azolidinonas de imidazopiridina.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition